Literature DB >> 24607449

Systemic immunotoxicity reactions induced by adjuvanted vaccines.

Alexander Batista-Duharte1, Deivys Portuondo2, O Pérez3, Iracilda Zeppone Carlos2.   

Abstract

Vaccine safety is a topic of concern for the treated individual, the family, the health care personnel, and the others involved in vaccination programs as recipients or providers. Adjuvants are necessary components to warrant the efficacy of vaccines, however the overstimulation of the immune system is also associated with adverse effects. Local reactions are the most frequent manifestation of toxicity induced by adjuvanted vaccines and, with the exception of the acute phase response (APR), much less is known about the systemic reactions that follow vaccination. Their low frequency or subclinical expression meant that this matter has been neglected. In this review, various systemic reactions associated with immune stimulation will be addressed, including: APR, hypersensitivity, induction or worsening of autoimmune diseases, modification of hepatic metabolism and vascular leak syndrome (VLS), with an emphasis on the mechanism involved. Finally, the authors analyze the current focus of discussion about vaccine safety and opportunities to improve the design of new adjuvanted vaccines in the future.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Action mechanisms; Adjuvant; Immunotoxicity; Systemic reactions; Vaccine

Mesh:

Substances:

Year:  2014        PMID: 24607449     DOI: 10.1016/j.intimp.2014.02.033

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  7 in total

1.  Autoimmune inflammatory rheumatic diseases post-COVID-19 vaccination.

Authors:  Azam Safary; Kamal Esalatmanesh; Amir Taher Eftekharsadat; Mohammad-Reza Jafari Nakjavani; Alireza Khabbazi
Journal:  Int Immunopharmacol       Date:  2022-07-15       Impact factor: 5.714

2.  Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant.

Authors:  Susan van Aalst; Irene S Ludwig; Ruurd van der Zee; Willem van Eden; Femke Broere
Journal:  PLoS One       Date:  2017-05-10       Impact factor: 3.240

Review 3.  Designing spatial and temporal control of vaccine responses.

Authors:  Gillie A Roth; Vittoria C T M Picece; Ben S Ou; Wei Luo; Bali Pulendran; Eric A Appel
Journal:  Nat Rev Mater       Date:  2021-09-28       Impact factor: 76.679

4.  Modulation of influenza vaccine immune responses using an epidermal growth factor receptor kinase inhibitor.

Authors:  Joanna A Pulit-Penaloza; Bishu Sapkota; E Stein Esser; Richard W Compans; Brian P Pollack; Ioanna Skountzou
Journal:  Sci Rep       Date:  2015-07-31       Impact factor: 4.379

Review 5.  Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines.

Authors:  Huub F J Savelkoul; Valerie A Ferro; Marius M Strioga; Virgil E J C Schijns
Journal:  Vaccines (Basel)       Date:  2015-03-05

6.  Antibody response of growing German Holstein bulls to a vaccination against bovine viral diarrhea virus (BVDV) is influenced by Fusarium toxin exposure in a non-linear fashion.

Authors:  Sven Dänicke; Janine Winkler; Ulrich Meyer; Susanne Kersten; Kerstin Wernike; Martin Beer; Jana Frahm
Journal:  Mycotoxin Res       Date:  2018-02-07       Impact factor: 3.833

Review 7.  Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety.

Authors:  Ronald N Kostoff; Darja Kanduc; Alan L Porter; Yehuda Shoenfeld; Daniela Calina; Michael B Briggs; Demetrios A Spandidos; Aristidis Tsatsakis
Journal:  Toxicol Rep       Date:  2020-10-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.